glutathione mutations in sclc patients Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation non-small-cell-lung-cancer Cell Death, Molecular Targeted Therapies,

Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR Mutant Lung Cancer JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Frontiers Metabolic reprogramming in lung cancer and its clinical implication Oxidative Stress and its Role in Carcinogenesis Cell Biochemistry and Biophysics Springer Nature Link Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death

SKU: 28175017098 · From creatorsinfotech.com